Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Year-over-year total asset growth rate
3Y CAGR
+3.4%/yr
vs -64.2%/yr prior
Acceleration
+67.6pp
Accelerating
Percentile
P56
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.44% |
| Q3 2025 | 0.94% |
| Q2 2025 | -1.53% |
| Q1 2025 | -5.99% |
| Q4 2024 | -12.39% |
| Q3 2024 | -11.90% |
| Q2 2024 | -0.41% |
| Q1 2024 | -2.55% |
| Q4 2023 | -17.53% |
| Q3 2023 | -0.22% |
| Q2 2023 | -3.01% |
| Q1 2023 | -2.88% |
| Q4 2022 | 0.40% |
| Q3 2022 | -1.80% |
| Q2 2022 | 3.47% |
| Q1 2022 | -1.52% |
| Q4 2021 | -1.53% |
| Q3 2021 | -2.81% |
| Q2 2021 | 0.24% |
| Q1 2021 | -0.92% |
| Q4 2020 | -12.19% |
| Q3 2020 | -5.49% |
| Q2 2020 | 10.43% |
| Q1 2020 | 20.62% |
| Q4 2019 | 3.48% |
| Q3 2019 | 11.21% |
| Q2 2019 | -6.29% |
| Q1 2019 | 9.92% |
| Q4 2018 | 3.61% |
| Q3 2018 | 1.45% |
| Q2 2018 | -6.65% |
| Q1 2018 | 0.61% |
| Q4 2017 | 3.47% |
| Q3 2017 | 3.07% |
| Q2 2017 | 7.13% |
| Q1 2017 | 2.96% |
| Q4 2016 | 3.97% |
| Q3 2016 | 3.74% |
| Q2 2016 | 3.86% |
| Q1 2016 | -9.03% |